| 1 |
De Backer D. Novelties in the evaluation of microcirculation in septic shock [J]. J Intensive Med, 2023, 3(2): 124-130.
|
| 2 |
Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021 [J]. Crit Care Med, 2021, 49(11): e1063-e1143.
|
| 3 |
Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 [J]. Intensive Care Med, 2017, 43(3): 304-377.
|
| 4 |
Lambden S, Creagh-Brown BC, Hunt J, et al. Definitions and pathophysiology of vasoplegic shock [J]. Crit Care, 2018, 22(1): 174.
|
| 5 |
Pluta MP, Putowski Z, Czempik PF, et al. Successful use of methylene blue in catecholamine-resistant septic shock: a case report and short literature review [J]. Int J Mol Sci, 2023, 24(13).
|
| 6 |
Jozwiak M. Alternatives to norepinephrine in septic shock: which agents and when? [J]. J Intensive Med, 2022, 2(4): 223-232.
|
| 7 |
Ratnani I, Ochani RK, Shaikh A, et al. Vasoplegia: a review [J]. Methodist Debakey Cardiovasc J, 2023, 19(4): 38-47.
|
| 8 |
Sari-Yavuz S, Heck-Swain KL, Keller M, et al. Methylene blue dosing strategies in critically ill adults with shock-A retrospective cohort study [J]. Front Med (Lausanne), 2022, 9: 1014276.
|
| 9 |
Hosseinian L, Weiner M, Levin MA, et al. Methylene blue: magic bullet for vasoplegia? [J]. Anesth Analg, 2016, 122(1): 194-201.
|
| 10 |
Ortiz F, Garcia JA, Acuna-Castroviejo D, et al. The beneficial effects of melatonin against heart mitochondrial impairment during sepsis: inhibition of iNOS and preservation of nNOS [J]. J Pineal Res, 2014, 56(1): 71-81.
|
| 11 |
Levy B, Collin S, Sennoun N, et al. Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside [J]. Intensive Care Med, 2010, 36(12): 2019-2029.
|
| 12 |
Lopez A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock [J]. Crit Care Med, 2004, 32(1): 21-30.
|
| 13 |
Singh J, Lee Y, Kellum JA. A new perspective on NO pathway in sepsis and ADMA lowering as a potential therapeutic approach [J]. Crit Care, 2022, 26(1): 246.
|
| 14 |
Chalise SN, Sahib TA, Boyer GA, et al. Methylene blue in refractory shock [J]. Cureus, 2022, 14(11): e31158.
|
| 15 |
Goncalves-Ferri WA, Albuquerque AAS, de Castro R, et al. Methylene blue to neonatal septic shock treatment in neonate pigs [J]. Clinics (Sao Paulo), 2022, 77: 100139.
|
| 16 |
Saha BK, Burns SL. The story of nitric oxide, sepsis and methylene blue: a comprehensive pathophysiologic review [J]. Am J Med Sci, 2020, 360(4): 329-337.
|
| 17 |
戴成, 王毅, 于湘友. 亚甲蓝治疗对脓毒症大鼠肺脏诱导型 一氧化氮合酶变化的影响 [J]. 中华危重病急救医学, 2016, 28(2): 134-139.
|
| 18 |
张雄峰, 戴成, 王毅, 等. 亚甲蓝对不同时期脓毒症大鼠肝脏诱导型一氧化氮合酶的影响 [J]. 中国中西医结合急救杂志, 2017, 24(3): 225-229.
|
| 19 |
Fernandes D, da Silva-Santos JE, Duma D, et al. Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity [J]. Mol Pharmacol, 2006, 69(3): 983-990.
|
| 20 |
Evgenov OV, Sager G, Bjertnaes LJ. Methylene blue reduces lung fluid filtration during the early phase of endotoxemia in awake sheep [J]. Crit Care Med, 2001, 29(2): 374-379.
|
| 21 |
赵光举, 李忠旺, 孙琦, 等. 血必净注射液对创伤弧菌脓毒症大鼠肺组织诱导型一氧化氮合酶及一氧化氮的影响 [J]. 中国中西医结合急救杂志, 2010, 17(2): 99-101.
|
| 22 |
王毅, 郗晓婧, 于湘友. 亚甲蓝对不同时期脓毒症大鼠心、肺功能的影响 [J]. 新疆医科大学学报, 2012, 35(7): 906-911.
|
| 23 |
Porizka M, Kopecky P, Dvorakova H, et al. Methylene blue administration in patients with refractory distributive shock - a retrospective study [J]. Sci Rep, 2020, 10(1): 1828.
|
| 24 |
陆雅萍, 郁惠杰, 刘倩影, 等. 亚甲蓝持续静脉输注对感染性休克患者的治疗效果 [J]. 中华医学杂志, 2019, 99(11): 868-871.
|
| 25 |
Ibarra-Estrada M, Kattan E, Aguilera-Gonzalez P, et al. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial [J]. Crit Care, 2023, 27(1): 110.
|
| 26 |
Guinot PG, Martin A, Berthoud V, et al. Vasopressor-sparing strategies in patients with shock: a scoping-review and an evidence-based strategy proposition [J]. J Clin Med, 2021, 10(14): 3164.
|
| 27 |
Schneider F, Lutun P, Hasselmann M, et al. Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations [J]. Intensive Care Med, 1992, 18(5): 309-311.
|
| 28 |
Preiser JC, Lejeune P, Roman A, et al. Methylene blue administration in septic shock: a clinical trial [J]. Crit Care Med, 1995, 23(2): 259-264.
|
| 29 |
Gachot B, Bedos JP, Veber B, et al. Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock [J]. Intensive Care Med, 1995, 21(12): 1027-1031.
|
| 30 |
Memis D, Karamanlioglu B, Yuksel M, et al. The influence of methylene blue infusion on cytokine levels during severe sepsis [J]. Anaesth Intensive Care, 2002, 30(6): 755-762.
|
| 31 |
Park BK, Shim TS, Lim CM, et al. The effects of methylene blue on hemodynamic parameters and cytokine levels in refractory septic shock [J]. Korean J Intern Med, 2005, 20(2): 123-128.
|
| 32 |
Weingartner R, Oliveira E, Oliveira ES, et al. Blockade of the action of nitric oxide in human septic shock increases systemic vascular resistance and has detrimental effects on pulmonary function after a short infusion of methylene blue [J]. Braz J Med Biol Res, 1999, 32(12): 1505-1513.
|
| 33 |
Juffermans NP, Vervloet MG, Daemen-Gubbels CR, et al. A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock [J]. Nitric Oxide, 2010, 22(4): 275-280.
|
| 34 |
Brown G, Frankl D, Phang T. Continuous infusion of methylene blue for septic shock [J]. Postgrad Med J, 1996, 72(852): 612-614.
|
| 35 |
Kirov MY, Evgenov OV, Evgenov NV, et al. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study [J]. Crit Care Med, 2001, 29(10): 1860-1867.
|
| 36 |
Ince C. Hemodynamic coherence and the rationale for monitoring the microcirculation [J]. Crit Care, 2015, 19(Suppl 3): S8.
|
| 37 |
Nantais J, Dumbarton TC, Farah N, et al. Impact of methylene blue in addition to norepinephrine on the intestinal microcirculation in experimental septic shock [J]. Clin Hemorheol Microcirc, 2014, 58(1): 97-105.
|
| 38 |
Maurin C, Portran P, Schweizer R, et al. Effects of methylene blue on microcirculatory alterations following cardiac surgery: A prospective cohort study [J]. Eur J Anaesthesiol, 2022, 39(4): 333-341.
|
| 39 |
陆雅萍, 刘倩影, 郁慧杰. 亚甲蓝对感染性休克患者动脉血气值和氧灌注指数的影响 [J]. 浙江医学, 2019, 41(6): 575-578.
|
| 40 |
Zhao CC, Zhai YJ, Hu ZJ, et al. Efficacy and safety of methylene blue in patients with vasodilatory shock: a systematic review and meta-analysis [J]. Front Med (Lausanne), 2022, 9: 950596.
|
| 41 |
Pruna A, Bonaccorso A, Belletti A, et al. Methylene blue reduces mortality in critically ill and perioperative patients: a meta-analysis of randomized trials [J]. J Cardiothorac Vasc Anesth, 2024, 38(1): 268-274.
|